Results 81 to 90 of about 7,263 (276)

Incidence and risk factor evaluation for postoperative nausea and vomiting in cesarean section under general anesthesia compared to the gynecologic surgery: A retrospective study

Journal of Obstetrics and Gynaecology Research, Volume 51, Issue 9, September 2025.
Abstract Aim This retrospective study sought to investigate the incidence of postoperative nausea and vomiting (PONV) and its associated risk factors in patients undergoing cesarean section under general anesthesia. Methods Patients who underwent cesarean section under general anesthesia or who underwent open gynecologic surgery were assigned to the OB
Su Yeon Kim, Seukyoung Hong, Jung‐Won Hwang, Sang‐Hwan Do, Hyo‐Seok Na   +4 more
wiley   +1 more source

Cost Effectiveness of First-Line Treatment with Doxorubicin/Ifosfamide Compared to Trabectedin Monotherapy in the Management of Advanced Soft Tissue Sarcoma in Italy, Spain, and Sweden [PDF]

, 2013
BACKGROUND: Doxorubicin/ifosfamide is a first-line systemic chemotherapy for the majority of advanced soft tissue sarcoma (ASTS) subtypes. Trabectedin is indicated for the treatment of ASTS after failure of anthracyclines and/or ifosfamide; however it is
Gough, N, Guest, JF, Linch, M, Panca, M, Sladkevicius, E   +4 more
core   +2 more sources

Dexamethasone‐Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High‐Dose Cisplatin: A Randomized Noninferiority Study

The Oncologist, 2021
Background To reduce the overall exposure to dexamethasone (DEX) in patients receiving cisplatin‐based chemotherapy, we evaluated the noninferiority of DEX on day 1, with or without low‐dose DEX on days 2 and 3, combined with an oral fixed‐dose ...
L. Celio, D. Cortinovis, A. Cogoni, L. Cavanna, O. Martelli, S. Carnio, E. Collovà, F. Bertolini, F. Petrelli, A. Cassano, R. Chiari, F. Zanelli, S. Pisconti, I. Vittimberga, A. Letizia, A. Misino, A. Gernone, E. Bonizzoni, S. Pilotto, S. De Placido, E. Bria   +20 more
semanticscholar   +1 more source

Prophylactic Effect of Prefrontal Alternating Current Stimulation on Postoperative Sleep Disturbance in Patients Undergoing Gynecological Laparoscope: A Randomized, Double‐Blind, Sham‐Controlled Trial

CNS Neuroscience &Therapeutics, Volume 31, Issue 8, August 2025.
A single preventive session of prefrontal tACS significantly reduces the incidence of PSD on the first postoperative day in patients undergoing gynecological laparoscopic surgery. ABSTRACT Aims Postoperative sleep disturbance (PSD) is a common complication following surgical procedures.
Ni Du, Jin‐Jin Yang, Xin‐Yu Li, Zhi‐Hao Li, Kenji Hashimoto, Lei Lei, Jian‐Jun Yang   +6 more
wiley   +1 more source

Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting

Drugs, 2021
Netupitant/palonosetron (NEPA; Akynzeo®), available in oral and intravenous (IV) formulations, is a fixed-dose combination of the neurokinin 1 (NK1) receptor antagonist netupitant (or the prodrug, fosnetupitant, in the IV formulation) and the second ...
M. Shirley
semanticscholar   +1 more source

Approach to the Management of Gastrointestinal Manifestations in Patients With Phaeochromocytoma and Paraganglioma

Clinical Endocrinology, Volume 103, Issue 1, Page 21-35, July 2025.
ABSTRACT Objective Managing gastrointestinal symptoms in patients with phaeochromocytoma and paraganglioma (PPGL) is challenging due to the risk of catecholaminergic crisis with many commonly prescribed medications, especially in functional tumours.
Monica Majumder, Cherie Chiang, Grace Kong, Michael Michael, Nirupa Sachithanandan, Emma Boehm   +5 more
wiley   +1 more source

Eficacia y seguridad del Palonosetron en comparacion con Ondansetron en el tratamiento de la Nausea y el Vomito inducido por Quimioterapia en Ninos con Cancer en el Hospital Materno Infantil, ISSEMYM [PDF]

, 2013
EFICACIA Y SEGURIDAD DEL PALONOSETRON EN COMPARACION CON ONDANSETRON EN EL TRATAMIENTO DE LA NAUSEA Y EL VOMITO INDUCIDO POR QUIMIOTERAPIA EN NIÑOS CON CANCER, TRATADOS EN EL HOSPITAL MATERNO INFANTIL ...
Gómez Medina, Mónica Patricia, López Facundo, Norma Araceli   +1 more
core  

Does a single dose of palonosetron have any role in preventing acute chemotherapy-induced nausea and vomiting in pediatric osteosarcoma patients without dexamethasone? A randomized clinical trial.

Advances in Clinical and Experimental Medicine, 2022
BACKGROUND Chemotherapy-induced nausea and vomiting (CINV) is a troublesome side-effect of chemotherapy in pediatric patients undergoing osteosarcoma treatment.
Zheng Li, Chun Li, Ping Li, Yugang Li, Jin Lai, S. Rastogi   +5 more
semanticscholar   +1 more source

Ratifying the efficacy and safety of intensive induction chemotherapy for acute myeloid leukaemia by the Australasian Leukaemia & Lymphoma Group consensus approach

Internal Medicine Journal, Volume 55, Issue 5, Page 749-759, May 2025.
Abstract Background After pharmaceutical benefits scheme approval of midostaurin for fms‐like tyrosine kinase 3 (FLT3)‐mutated acute myeloid leukaemia (AML) in 2018, the Australasian Leukaemia & Lymphoma Group (ALLG) proposed a consensus approach to AML induction with 7+3 chemotherapy (7 days of infusional cytarabine with three doses of anthracycline ...
Aditya Tedjaseputra, Amanda Tey, Anastasios Nalpantidis, George Grigoriadis, Shaun Fleming, Shahla Vilcassim, Pasquale L. Fedele, Michael Sze Yuan Low, Paul Yeh, Michael Gilbertson, Ashwini Bennett, Gareth P. Gregory, Danielle Oh, Donna Gairns, Zane Kaplan, Sanjeev D. Chunilal, Susan Brown, Stephen Opat, Chong C. Chua, Jake Shortt   +19 more
wiley   +1 more source

A prospective, randomized, double-blind trial to compare body weight-adjusted and fixed doses of palonosetron for preventing postoperative nausea and vomiting in obese female patients.

PLoS ONE, 2020
BackgroundPostoperative nausea and vomiting (PONV) is a common postsurgical complication. Palonosetron is effective for PONV prevention at the usual dose of 75 μg, but the ideal dose for obese patients has not yet been investigated. The aim of this study
Nathalia Gouveia de Araujo Ferreira, Ismar Lima Cavalcanti, Alexandra Rezende Assad, Louis Barrucand, Estêvão Luiz Carvalho Braga, Nubia Verçosa   +5 more
doaj   +1 more source